Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Adam Kibel, M.D.


This page shows the publications co-authored by Adam Kibel and Li Jia.
Connection Strength

  1. Androgen receptor-regulated miRNA-193a-3p targets AJUBA to promote prostate cancer cell migration. Prostate. 2017 Jun; 77(9):1000-1011.
    View in: PubMed
    Score: 0.733
  2. Selective targeting of PARP-2 inhibits androgen receptor signaling and prostate cancer growth through disruption of FOXA1 function. Proc Natl Acad Sci U S A. 2019 07 16; 116(29):14573-14582.
    View in: PubMed
    Score: 0.213
  3. Targeting the MIF/CXCR7/AKT Signaling Pathway in Castration-Resistant Prostate Cancer. Mol Cancer Res. 2019 01; 17(1):263-276.
    View in: PubMed
    Score: 0.202
  4. Functional roles and potential clinical application of miRNA-345-5p in prostate cancer. Prostate. 2018 09; 78(12):927-937.
    View in: PubMed
    Score: 0.197
  5. Androgen receptor-mediated downregulation of microRNA-221 and -222 in castration-resistant prostate cancer. PLoS One. 2017; 12(9):e0184166.
    View in: PubMed
    Score: 0.188
  6. The association between germline BRCA2 variants and sensitivity to platinum-based chemotherapy among men with metastatic prostate cancer. Cancer. 2017 Sep 15; 123(18):3532-3539.
    View in: PubMed
    Score: 0.046
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.